# Gershwin Blyden, M.D. – FDA Inspection, Sep 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/gershwin-blyden-md/b18a1885-fdf8-433d-bca9-e4e4a3836278
Source feed: FDA_Inspections

> FDA inspection 1101941 of Gershwin Blyden, M.D., September 12, 2019. Classification: No Action Indicated (NAI). 3 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101941
- Company Name: Gershwin Blyden, M.D.
- Inspection Date: 2019-09-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [Company Rep](https://www.keypedia.com/people/traci-m-armand/3af556f9-942c-4e58-85ee-f7d261a236ce)

Company: https://www.keypedia.com/companies/gershwin-blyden-md/4029a7c3-0883-4547-ad50-44c6a39b0927

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c